PE anti-human CD209 (DC-SIGN) Antibody
- 产品名称：
- PE anti-human CD209 (DC-SIGN) Antibody
- 产品类别：
- 抗体
- 产品编号：
- 330105
- 产品应用：
- 330105
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1608 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Extracellular domain of human DC-SIGN
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
Additional reported applications (for the relevant formats) include: immunohistochemistry on frozen tissue sections1?and spatial biology (IBEX)2,3.
- Application References
(PubMed link indicates BioLegend citation) -
- Granelli-Piperno A, et al. 2005. J Immunol. 175:4265. (IHC-F)
- Radtke AJ,?et al. 2020.?Proc Natl Acad Sci USA. 117:33455-33465. (SB)?PubMed
- Radtke AJ,?et al. 2022.?Nat Protoc. 17:378-401. (SB)?PubMed
- Product Citations
-
- Gao R, et al. 2021. iScience. 24:103133. PubMed
- Chometon TQ, et al. 2020. PLoS One. 15:e0231132. PubMed
- Barrett TJ, et al. 2021. J Thromb Haemost. 19:3139. PubMed
- Azad A, et al. 2015. J Immunol. 195: 2019-2029. PubMed
- Svajger U, et al. 2011. J Leukoc Biol. 89:893. PubMed
- Barman S, et al. 2016. Int Immunol. 28: 533 - 545. PubMed
- Yu X, et al. 2021. Commun Biol. 4:772. PubMed
- Shin CH, et al. 2020. J Immunol. 205:3179. PubMed
- van Doorn CLR, et al. 2021. Front Immunol. 12:712021. PubMed
- Pahk KJ, et al. 2019. Sci Rep. 9:9050. PubMed
- RRID
- AB_1134060 (BioLegend Cat. No. 330105) AB_1134052 (BioLegend Cat. No. 330106)
